| Whole body PD-1 and PD-L1 positron emission tomography in patients with non-small-cell lung cancer AN Niemeijer, D Leung, MC Huisman, I Bahce, OS Hoekstra, ... Nature communications 9 (1), 4664, 2018 | 419 | 2018 |
| ERα-dependent E2F transcription can mediate resistance to estrogen deprivation in human breast cancer TW Miller, JM Balko, EM Fox, Z Ghazoui, A Dunbier, H Anderson, ... Cancer discovery 1 (4), 338-351, 2011 | 362 | 2011 |
| A kinome-wide screen identifies the insulin/IGF-I receptor pathway as a mechanism of escape from hormone dependence in breast cancer EM Fox, TW Miller, JM Balko, MG Kuba, V Sánchez, RA Smith, S Liu, ... Cancer research 71 (21), 6773-6784, 2011 | 186 | 2011 |
| Synthesis and biologic evaluation of a novel 18F-labeled adnectin as a PET radioligand for imaging PD-L1 expression DJ Donnelly, RA Smith, P Morin, D Lipovšek, J Gokemeijer, D Cohen, ... Journal of Nuclear Medicine 59 (3), 529-535, 2018 | 179 | 2018 |
| Limits of [18F]-FLT PET as a Biomarker of Proliferation in Oncology ET McKinley, GD Ayers, RA Smith, SA Saleh, P Zhao, MK Washington, ... PloS one 8 (3), e58938, 2013 | 132 | 2013 |
| Radiosynthesis and preclinical PET evaluation of 89Zr-nivolumab (BMS-936558) in healthy non-human primates EL Cole, J Kim, DJ Donnelly, RA Smith, D Cohen, V Lafont, PE Morin, ... Bioorganic & medicinal chemistry 25 (20), 5407-5414, 2017 | 90 | 2017 |
| Real-time assessment of inflammation and treatment response in a mouse model of allergic airway inflammation V Cortez-Retamozo, FK Swirski, P Waterman, H Yuan, JL Figueiredo, ... The Journal of clinical investigation 118 (12), 4058-4066, 2008 | 86 | 2008 |
| Quantitative, preclinical PET of translocator protein expression in glioma using 18F-N-fluoroacetyl-N-(2, 5-dimethoxybenzyl)-2-phenoxyaniline JR Buck, ET McKinley, MR Hight, A Fu, D Tang, RA Smith, MN Tantawy, ... Journal of Nuclear Medicine 52 (1), 107-114, 2011 | 74 | 2011 |
| Quantitative preclinical imaging of TSPO expression in glioma using N, N-diethyl-2-(2-(4-(2-18F-fluoroethoxy) phenyl)-5, 7-dimethylpyrazolo [1, 5-a] pyrimidin-3-yl) acetamide D Tang, MR Hight, ET McKinley, A Fu, JR Buck, RA Smith, MN Tantawy, ... Journal of Nuclear Medicine 53 (2), 287-294, 2012 | 72 | 2012 |
| Characterizing tumor response to chemotherapy at various length scales using temporal diffusion spectroscopy J Xu, K Li, RA Smith, JC Waterton, P Zhao, H Chen, MD Does, ... PloS one 7 (7), e41714, 2012 | 58 | 2012 |
| Phase 2 trial design of BMS-986278, a lysophosphatidic acid receptor 1 (LPA1) antagonist, in patients with idiopathic pulmonary fibrosis (IPF) or progressive fibrotic … TJ Corte, L Lancaster, JJ Swigris, TM Maher, JG Goldin, SM Palmer, ... BMJ open respiratory research 8 (1), e001026, 2021 | 35 | 2021 |
| Quantitative measurement of multifunctional quantum dot binding to cellular targets using flow cytometry RA Smith, TD Giorgio Cytometry Part A: The Journal of the International Society for Advancement …, 2009 | 33 | 2009 |
| 3′-deoxy-3′-18F-fluorothymidine PET predicts response to V600EBRAF-targeted therapy in preclinical models of colorectal cancer ET McKinley, RA Smith, P Zhao, A Fu, SA Saleh, MI Uddin, ... Journal of Nuclear Medicine 54 (3), 424-430, 2013 | 31 | 2013 |
| Synthesis and preclinical evaluation of a 68Ga-labeled adnectin, 68Ga-BMS-986192, as a PET agent for imaging PD-L1 expression S Robu, A Richter, D Gosmann, C Seidl, D Leung, W Hayes, D Cohen, ... Journal of Nuclear Medicine 62 (9), 1228-1234, 2021 | 29 | 2021 |
| The antiproliferative cytostatic effects of a self-activating viridin prodrug A Smith, J Blois, H Yuan, E Aikawa, C Ellson, JL Figueiredo, R Weissleder, ... Molecular cancer therapeutics 8 (6), 1666-1675, 2009 | 27 | 2009 |
| PD-L1 binding polypeptides for imaging PE Morin, D Donnelly, D Lipovsek, J Gokemeijer, MN Jure-kunkel, ... US Patent 10,406,251, 2019 | 24 | 2019 |
| IASLC CT Screening Workshop 2011 Participants. International association for the study of lung cancer computed tomography screening workshop 2011 report JK Field, RA Smith, DR Aberle, M Oudkerk, DR Baldwin, D Yankelevitz, ... J Thorac Oncol 7 (1), 10-19, 2012 | 21 | 2012 |
| Proximity-activated nanoparticles: in vitro performance of specific structural modification by enzymatic cleavage R Adam Smith, SL Sewell, TD Giorgio International journal of nanomedicine 3 (1), 95-103, 2008 | 21 | 2008 |
| Fate of a bioactive fluorescent wortmannin derivative in cells KR Barnes, J Blois, A Smith, H Yuan, F Reynolds, R Weissleder, ... Bioconjugate chemistry 19 (1), 130-137, 2008 | 21 | 2008 |
| Slow self-activation enhances the potency of viridin prodrugs J Blois, H Yuan, A Smith, ME Pacold, R Weissleder, LC Cantley, ... Journal of medicinal chemistry 51 (15), 4699-4707, 2008 | 19 | 2008 |
Eliot T. McKinleyPrincipal Bioimaging Data Scientist, GSKVerified email at gsk.com
